RepliCel Life Sciences Inc.

DB:P6P2 Stock Report

Market Cap: €129.3k

RepliCel Life Sciences Inc. Company Information

RepliCel Life Sciences Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: RepliCel Life Sciences Inc.
  • Ticker: P6P2
  • Exchange: DB
  • Founded: NaN
  • Industry: Life Sciences Tools and Services
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$136.503k
  • Listing Market Cap: US$129.337k
  • Shares Outstanding: 65.00m
  • Website: https://www.replicel.com

Number of Employees


Location

  • RepliCel Life Sciences Inc.
  • 570 Granville Street
  • Suite 900
  • Vancouver
  • British Columbia
  • V6C 3P1
  • Canada


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
REPC.FOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDDec 2009
P6P2DB (Deutsche Boerse AG)YesCommon SharesDEEURDec 2009
RPTSXV (TSX Venture Exchange)YesCommon SharesCACADDec 2009

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/28 01:25
End of Day Share Price 2024/11/28 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.